- Home
- DX vs QURE Comparison
DX vs QURE Comparison
Compare DX & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DX | QURE |
|---|---|---|
| Founded | 1987 | 1998 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | DX | QURE |
|---|---|---|
| Price | $14.05 | $27.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 13 |
| Target Price | $14.25 | ★ $56.25 |
| AVG Volume (30 Days) | ★ 7.6M | 1.9M |
| Earning Date | 01-26-2026 | 02-26-2026 |
| Dividend Yield | ★ 14.76% | N/A |
| EPS Growth | ★ 65.77 | N/A |
| EPS | ★ 2.47 | N/A |
| Revenue | ★ $372,113,000.00 | $15,751,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $142.93 |
| P/E Ratio | $5.60 | ★ N/A |
| Revenue Growth | ★ 147.42 | N/A |
| 52 Week Low | $10.79 | $7.76 |
| 52 Week High | $14.93 | $71.50 |
Technical Indicators
Market Signals| Indicator | DX | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 44.34 | 61.18 |
| Support Level | $13.69 | $22.32 |
| Resistance Level | $14.93 | $25.80 |
| Average True Range (ATR) | 0.31 | 1.66 |
| MACD | -0.08 | 0.50 |
| Stochastic Oscillator | 22.57 | 87.79 |
Price Performance
Historical ComparisonAbout DX Dynex Capital Inc.
Dynex Capital Inc is an internally managed mortgage real estate investment trust, which invests in mortgage-backed securities. The company invests in residential and commercial mortgage-backed securities. Its objective is to provide attractive risk-adjusted returns to shareholders over the long term that are reflective of a leveraged, high quality fixed income portfolio with a focus on capital preservation. Its investments consist principally of Agency mortgage-backed securities including, residential MBS and commercial MBS.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.